HomeAPGE • NASDAQ
add
Apogee Therapeutics Inc
Previous close
$45.86
Day range
$44.52 - $47.47
Year range
$14.19 - $72.29
Market cap
2.66B USD
Avg Volume
665.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 37.16M | 119.95% |
Net income | -31.74M | -80.07% |
Net profit margin | — | — |
Earnings per share | -0.32 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 395.46M | 160.36% |
Total assets | 401.40M | 163.99% |
Total liabilities | 21.49M | 115.34% |
Total equity | 379.91M | — |
Shares outstanding | 50.66M | — |
Price to book | 6.11 | — |
Return on assets | -22.44% | — |
Return on capital | -23.48% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -31.74M | -80.07% |
Cash from operations | -29.75M | -178.53% |
Cash from investing | -39.69M | — |
Cash from financing | -213.00K | -100.12% |
Net change in cash | -69.66M | -142.71% |
Free cash flow | -18.28M | — |
About
Founded
2022
Headquarters
Website
Employees
91